SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-151875
Filing Date
2024-05-31
Accepted
2024-05-31 16:38:22
Documents
6
Effectiveness Date
2024-05-31

Document Format Files

Seq Description Document Type Size
1 S-8 POS d833955ds8pos.htm S-8 POS 95893
2 EX-5.1 d833955dex51.htm EX-5.1 25794
3 EX-23.1 d833955dex231.htm EX-23.1 1747
4 GRAPHIC g833955g0530175507005.jpg GRAPHIC 2494
5 GRAPHIC g833955g0530175507150.jpg GRAPHIC 3385
6 GRAPHIC g833955g0530175507286.jpg GRAPHIC 3744
  Complete submission text file 0001193125-24-151875.txt   138211
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-187316 | Film No.: 241010315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)